| 000 | 01673nam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223025620.0 | ||
| 008 | 090521s2009 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng. | |
| 049 | _aDeposite | ||
| 097 | _aPh.D. | ||
| 099 | _aCai01.11.07.Ph.D.2009.Ha.P | ||
| 100 | 0 | _aHanaa Abdelkader Aboubakr | |
| 245 | 1 | 4 |
_aThe prognostic significance of chromosome 11 q22.3 deletion in chronic lymphocytic leukemia / _cHanaa Abdelkader Aboubakr ; Supervised Hala Fathy Sheba , Nesrine M. Elgharbawi , Nermine A. Dessoki |
| 246 | 1 | 5 | _aالدلالة الإكلينيكية للمحو بالذراع الطويل لكروموزوم 11 فى الأورام الليمفاوية المزمنة |
| 260 |
_aCairo : _bHanaa Abdelkader Aboubakr , _c2009 |
||
| 300 |
_a172P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _aB-cell malignancies (B-CLL) are heterogeneous malignant diseases; they share a common cell lineage but a wide range of clinical behavior and outcomes.The most frequent chromosomal aberrations in B-CLL are deletions 13q,11q, 17p and trisomy 12,all of which are of prognostic sibnificance | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _a11q22.3 | |
| 653 | 4 | _aCLL | |
| 653 | 4 | _aFish | |
| 700 | 0 |
_aHala Fathy Sheba , _eSupervisor |
|
| 700 | 0 |
_aNermine A. Dessoki , _eSupervisor |
|
| 700 | 0 |
_aNesrine Mohamed Elgharbawi , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c16786 _d16786 |
||